CCL4 and atherosclerosis: In addition, high-dose CCL4 antibody treatments not only improved the metabolic profiles at least partially by upregulating LXR expression, but also reduced the circulating inflammatory cytokines, suggesting systemic anti-inflammatory effects on atherosclerosis.